• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨保护素基因163A/G和1181G/C多态性与骨密度的关联

Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.

作者信息

García-Unzueta M T, Riancho J A, Zarrabeitia M T, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J, Amado J A

机构信息

Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, University of Cantabria, Santander, Spain.

出版信息

Horm Metab Res. 2008 Mar;40(3):219-24. doi: 10.1055/s-2008-1046793.

DOI:10.1055/s-2008-1046793
PMID:18348083
Abstract

The aim of the study was to investigate the distribution of 163 A/G osteoprotegerin gene promoter and 1181 G/C osteoprotegerin exon 1 polymorphisms in a group of women with different hormonal status and to analyze their relationship with BMD. Osteoprotegerin polymorphisms and BMD were analyzed in 332 women (69 premenopausal and 263 postmenopausal). BMD was quantified at the lumbar spine (L 2-4), femoral neck, and total hip. Genotyping for the presence of different polymorphisms was performed using the Custom Taqman ((R)) SNP Genotyping assays. There were not significant differences in BMD according to 163 A/G genotype. However, significant differences in lumbar spine BMD were found according to 1181 G/C alleles. Thus, women with CC genotype had significant higher BMD at the lumbar spine than those with GC or GG genotype. No differences were found in femoral neck and total hip BMD. In age-adjusted models, the 1181 G/C OPG polymorphism explained 2.2% of BMD variance at the spine, 0.3% at the femoral neck, and 0.9% at the total hip in the whole group. In the subgroup of premenopausal women, the polymorphism was strongly related to spine BMD, and explained 11.5% of the variance, whereas body weight explained 7.9%. The 1181 G/C polymorphism was associated with lumbar spine BMD in Spanish women. Premenopausal women with the CC genotype had a higher BMD.

摘要

本研究的目的是调查163A/G骨保护素基因启动子和1181G/C骨保护素外显子1多态性在一组具有不同激素状态的女性中的分布情况,并分析它们与骨密度的关系。对332名女性(69名绝经前女性和263名绝经后女性)的骨保护素多态性和骨密度进行了分析。在腰椎(L2-4)、股骨颈和全髋部对骨密度进行了量化。使用定制Taqman(R)SNP基因分型检测法对不同多态性的存在进行基因分型。根据163A/G基因型,骨密度没有显著差异。然而,根据1181G/C等位基因,在腰椎骨密度上发现了显著差异。因此,CC基因型的女性在腰椎的骨密度显著高于GC或GG基因型的女性。在股骨颈和全髋部骨密度方面未发现差异。在年龄调整模型中,1181G/C骨保护素多态性在整个组中解释了脊柱骨密度变异的2.2%、股骨颈骨密度变异的0.3%和全髋部骨密度变异的0.9%。在绝经前女性亚组中,该多态性与脊柱骨密度密切相关,解释了11.5%的变异,而体重解释了7.9%的变异。1181G/C多态性与西班牙女性的腰椎骨密度相关。CC基因型的绝经前女性骨密度较高。

相似文献

1
Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.骨保护素基因163A/G和1181G/C多态性与骨密度的关联
Horm Metab Res. 2008 Mar;40(3):219-24. doi: 10.1055/s-2008-1046793.
2
Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.骨保护素基因多态性与日本女性而非男性骨密度的关联。
Mol Genet Metab. 2003 Nov;80(3):344-9. doi: 10.1016/S1096-7192(03)00125-2.
3
Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.韩国绝经后女性中骨保护素(OPG)、核因子κB受体激活剂(RANK)和RANK配体(RANKL)基因多态性与循环OPG、可溶性RANKL水平及骨密度之间的关联。
Menopause. 2007 Sep-Oct;14(5):913-8. doi: 10.1097/gme.0b013e31802d976f.
4
Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.绝经后女性骨保护素基因多态性与骨密度的关联
Maturitas. 2005 Jul 16;51(3):270-9. doi: 10.1016/j.maturitas.2004.08.006.
5
Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.绝经后女性中内皮型一氧化氮合酶(eNOS)基因多态性与骨密度(BMD)关系的评估。
Maturitas. 2009 Aug 20;63(4):352-6. doi: 10.1016/j.maturitas.2009.05.004. Epub 2009 Jun 10.
6
TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.TNFRSF11B 基因多态性 1181G>C 和 245T>G 以及单体型 CT 影响绝经后妇女的骨密度。
Maturitas. 2011 Jul;69(3):263-7. doi: 10.1016/j.maturitas.2011.02.010. Epub 2011 Mar 15.
7
Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.RUNX2基因启动子2 -1025 T/C多态性与西班牙绝经后女性的股骨颈骨密度相关。
Calcif Tissue Int. 2007 Oct;81(4):327-32. doi: 10.1007/s00223-007-9069-2. Epub 2007 Sep 19.
8
Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.中国绝经后女性骨保护素基因单核苷酸多态性及其与骨密度的关系
J Pediatr Endocrinol Metab. 2012;25(11-12):1141-4. doi: 10.1515/jpem-2012-0274.
9
[Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].[骨保护素基因多态性对绝经后女性骨量的影响]
Zhonghua Yi Xue Za Zhi. 2004 Feb 17;84(4):274-7.
10
The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.维生素D受体、骨保护素和肿瘤坏死因子超家族成员11基因多态性的组合与骨密度相关。
J Mol Endocrinol. 2009 Mar;42(3):239-47. doi: 10.1677/JME-08-0108. Epub 2009 Jan 8.

引用本文的文献

1
Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women.骨保护素基因作为绝经后女性骨质疏松症发生发展的生物标志物
Biomedicines. 2023 Dec 4;11(12):3218. doi: 10.3390/biomedicines11123218.
2
Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.骨保护素基因多态性及其对绝经后骨质疏松女性伊班膦酸盐治疗反应的影响。
PLoS One. 2023 Sep 26;18(9):e0291959. doi: 10.1371/journal.pone.0291959. eCollection 2023.
3
Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity.
2 型固有和适应性免疫调节的炎症性关节炎和骨代谢
Int J Mol Sci. 2022 Jan 20;23(3):1104. doi: 10.3390/ijms23031104.
4
The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.绝经后女性骨保护素(OPG)基因多态性与骨密度(BMD)之间的遗传关联:一项荟萃分析。
Medicine (Baltimore). 2018 Dec;97(51):e13507. doi: 10.1097/MD.0000000000013507.
5
A comprehensive overview on osteoporosis and its risk factors.骨质疏松症及其风险因素综述
Ther Clin Risk Manag. 2018 Nov 6;14:2029-2049. doi: 10.2147/TCRM.S138000. eCollection 2018.
6
Polymorphism rs2073618 of the () Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis.()基因 rs2073618 多态性与墨西哥类风湿关节炎女性的骨密度。
J Immunol Res. 2017;2017:7680434. doi: 10.1155/2017/7680434. Epub 2017 Jul 5.
7
Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.炎症性肠病患者骨代谢与骨保护素基因5'UTR区域c.-223C>T多态性
Calcif Tissue Int. 2016 Dec;99(6):616-624. doi: 10.1007/s00223-016-0192-9. Epub 2016 Sep 17.
8
rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration.rs2073617基因多态性与骨保护素(OPG)蛋白表达上调及椎间盘退变风险增加有关。
Exp Ther Med. 2016 Aug;12(2):702-710. doi: 10.3892/etm.2016.3342. Epub 2016 May 16.
9
Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).社区居住老年人群中骨保护素(OPG)和核因子κB受体活化因子配体(RANKL)基因多态性与椎体骨折及腹主动脉钙化的关联:圣保罗衰老与健康研究(SPAH)
Osteoporos Int. 2016 Nov;27(11):3319-3329. doi: 10.1007/s00198-016-3664-x. Epub 2016 Jun 16.
10
Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.汉族绝经后女性中CNR2基因常见变异对骨密度和骨质疏松易感性的评估
Osteoporos Int. 2015 Dec;26(12):2803-10. doi: 10.1007/s00198-015-3195-x. Epub 2015 Jun 9.